Concepedia

Pedro Garbes

PG

4

Publications

409

Citations

4

H-Index

2013

Active since

Affiliations

Secretaría Nacional de Ciencia, Tecnología e Innovación(Current)

Takeda (United States)

De La Salle University – Dasmariñas

Takeda (Switzerland)

Takeda (Singapore)

Pedro Garbes is an author at Secretaría Nacional de Ciencia, Tecnología e Innovación specializing in vaccination, vaccine safety, and medicine.

Top concepts

Publications per year

2013–2020

4

Publications

4

Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Shibadas Biswal, Charissa Borja-Tabora, Luis Martinez Vargas et al. · The Lancet · 2020 · 237 citations

, , +5

Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study

Xavier Sáez‐Llorens, Vianney Tricou, Delia Yu et al. · The Lancet Infectious Diseases · 2017 · 88 citations

, , +12

Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil

Gustavo H. Dayan, Pedro Garbes, Fernando Noriega et al. · American Journal of Tropical Medicine and Hygiene · 2013 · 60 citations · Full text

, , +13

Prospective Cohort Study with Active Surveillance for Fever in Four Dengue Endemic Countries in Latin America

Gustavo H. Dayan, José Luis Arredondo-Garcı́a, Gabriel Carrasquilla et al. · American Journal of Tropical Medicine and Hygiene · 2015 · 24 citations · Full text

Rows per page

1–4 of 4